Crimean-Congo hemorrhagic fever
ICD-10 A98.4 is a billable code used to indicate a diagnosis of crimean-congo hemorrhagic fever.
Crimean-Congo hemorrhagic fever (CCHF) is a viral disease caused by the Crimean-Congo hemorrhagic fever virus (CCHFV), a member of the Nairovirus genus within the Bunyaviridae family. It is primarily transmitted to humans through tick bites or contact with infected animal blood or tissues. The disease is endemic in parts of Africa, the Balkans, the Middle East, and Central Asia. Symptoms typically begin with fever, myalgia, and dizziness, progressing to more severe manifestations such as hemorrhagic signs, including bleeding from the gums, nose, and gastrointestinal tract. The case fatality rate can be as high as 30%, making it a significant public health concern. Diagnosis is often confirmed through serological tests or PCR assays. Given its potential for outbreaks and the risk of severe disease, healthcare providers must be vigilant, especially in endemic regions or among travelers returning from these areas. Proper coding for CCHF is essential for accurate epidemiological tracking and resource allocation in healthcare settings.
Detailed travel history, exposure risks, and laboratory confirmation.
Patients presenting with fever and bleeding after travel to endemic areas.
Ensure thorough documentation of symptoms and exposure to facilitate accurate coding.
Immediate assessment of symptoms, travel history, and potential exposure.
Patients with acute febrile illness and a history of travel to endemic regions.
Rapid identification and documentation are crucial for timely intervention.
Used for confirming CCHF diagnosis through PCR testing.
Document the need for testing based on clinical presentation and travel history.
Infectious disease specialists should ensure proper test selection.
CCHF is primarily transmitted through tick bites, contact with infected animal blood or tissues, and, in rare cases, human-to-human transmission through bodily fluids.
